Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Bases de dados
Ano de publicação
Tipo de documento
Intervalo de ano de publicação
1.
Hum Vaccin Immunother ; 13(11): 2612-2625, 2017 11 02.
Artigo em Inglês | MEDLINE | ID: mdl-28933657

RESUMO

Dengue virus (DV) is the etiologic agent of dengue fever, the most significant mosquito-borne viral disease in humans. Most DV vaccine approaches are focused on generating antibody mediated responses; one such DV vaccine is approved for use in humans but its efficacy is limited. While it is clear that T cell responses play important role in DV infection and subsequent disease manifestations, fewer studies are aimed at developing vaccines that induce robust T cells responses. Potent T cell based vaccines require 2 critical components: the identification of specific T cell stimulating MHC associated peptides, and an optimized vaccine delivery vehicle capable of simultaneously delivering the antigens and any required adjuvants. We have previously identified and characterized DV specific HLA-A2 and -A24 binding DV serotypes conserved epitopes, and the feasibility of an epitope based vaccine for DV infection. In this study, we build on those previous studies and describe an investigational DV vaccine using T cell epitopes incorporated into a calcium phosphate nanoparticle (CaPNP) delivery system. This study presents a comprehensive analysis of functional immunogenicity of DV CaPNP/multipeptide formulations in vitro and in vivo and demonstrates the CaPNP/multipeptide vaccine is capable of inducing T cell responses against all 4 serotypes of DV. This synthetic vaccine is also cost effective, straightforward to manufacture, and stable at room temperature in a lyophilized form. This formulation may serve as an effective candidate DV vaccine that protects against all 4 serotypes as either a prophylactic or therapeutic vaccine.


Assuntos
Fosfatos de Cálcio/química , Vacinas contra Dengue/imunologia , Epitopos de Linfócito T/química , Imunização/métodos , Nanopartículas/administração & dosagem , Nanopartículas/química , Animais , Animais Geneticamente Modificados , Antígenos Virais/química , Antígenos Virais/imunologia , Fosfatos de Cálcio/administração & dosagem , Dengue/imunologia , Dengue/prevenção & controle , Dengue/terapia , Vacinas contra Dengue/administração & dosagem , Vacinas contra Dengue/efeitos adversos , Vacinas contra Dengue/economia , Vírus da Dengue/química , Vírus da Dengue/imunologia , Sistemas de Liberação de Medicamentos , Epitopos de Linfócito T/imunologia , Antígeno HLA-A2/imunologia , Humanos , Imunogenicidade da Vacina , Camundongos , Linfócitos T/imunologia , Vacinas de Subunidades Antigênicas/administração & dosagem , Vacinas de Subunidades Antigênicas/efeitos adversos , Vacinas de Subunidades Antigênicas/economia , Vacinas de Subunidades Antigênicas/imunologia , Vacinas Sintéticas/administração & dosagem , Vacinas Sintéticas/efeitos adversos , Vacinas Sintéticas/economia , Vacinas Sintéticas/imunologia
2.
Biochem Biophys Res Commun ; 425(2): 207-11, 2012 Aug 24.
Artigo em Inglês | MEDLINE | ID: mdl-22835932

RESUMO

A molecular model of mature dengue virus envelope building block consisting of two E and two M protein subunits is constructed. Monte Carlo optimisation is performed for the model in the implicit membrane system. Interactions between the ectodomains and membrane parts of E and M proteins are studied, and possible role of conserved residues is suggested. The opening of E protein detergent binding site and its fixation in the open state by the M non-structured loop is observed.


Assuntos
Simulação por Computador , Vírus da Dengue/química , Modelos Moleculares , Proteínas do Envelope Viral/química , Cristalografia por Raios X , Método de Monte Carlo , Estrutura Terciária de Proteína
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA